Cantel Medical (CMD) Earning Somewhat Favorable Media Coverage, Study Finds

News stories about Cantel Medical (NYSE:CMD) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cantel Medical earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 45.2778334551637 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Shares of Cantel Medical (NYSE CMD) opened at $113.10 on Monday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.48 and a current ratio of 2.44. The stock has a market cap of $4,730.00, a price-to-earnings ratio of 62.49 and a beta of 1.25. Cantel Medical has a 1-year low of $69.21 and a 1-year high of $113.45.

Cantel Medical (NYSE:CMD) last posted its quarterly earnings data on Thursday, December 7th. The company reported $0.57 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.05. Cantel Medical had a net margin of 9.50% and a return on equity of 17.42%. analysts anticipate that Cantel Medical will post 2.35 earnings per share for the current year.

The company also recently disclosed a Semi-Annual dividend, which will be paid on Wednesday, January 31st. Investors of record on Wednesday, January 17th will be issued a dividend of $0.085 per share. This is an increase from Cantel Medical’s previous Semi-Annual dividend of $0.07. This represents a dividend yield of 0.17%. The ex-dividend date is Tuesday, January 16th. Cantel Medical’s dividend payout ratio is currently 9.39%.

TRADEMARK VIOLATION NOTICE: “Cantel Medical (CMD) Earning Somewhat Favorable Media Coverage, Study Finds” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright law. The original version of this story can be viewed at https://www.dispatchtribunal.com/2018/01/22/cantel-medical-cmd-earning-somewhat-favorable-media-coverage-study-finds.html.

About Cantel Medical

Cantel Medical Corp. is a provider of infection prevention products and services in the healthcare market. The Company’s operating segments include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.

Insider Buying and Selling by Quarter for Cantel Medical (NYSE:CMD)

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply